New approach for oral administration of insulin with polyalkylcyanoacrylate nanocapsules as drug carrier.
about
Oral insulinOral insulin delivery: how far are we?A review on the strategies for oral delivery of proteins and peptides and their clinical perspectivesNanoparticle based insulin delivery system: the next generation efficient therapy for Type 1 diabetesA review of the efficacy and safety of nanoparticle-based oral insulin delivery systemsThe intestinal uptake of particles and the implications for drug and antigen deliveryOral delivery of insulin for treatment of diabetes: status quo, challenges and opportunities.Novel PLGA-based nanoparticles for the oral delivery of insulin.pH-sensitive poly(lactide-co-glycolide) nanoparticle composite microcapsules for oral delivery of insulin.Novel complexation hydrogels for oral peptide delivery: in vitro evaluation of their cytocompatibility and insulin-transport enhancing effects using Caco-2 cell monolayers.Past, present, and future technologies for oral delivery of therapeutic proteins.The performance of nanocarriers for transmucosal drug delivery.Polymeric particulates to improve oral bioavailability of peptide drugs.Design aspects of poly(alkylcyanoacrylate) nanoparticles for drug delivery.Nanoparticle strategies for the oral delivery of insulin.Biodistribution studies of protein cage nanoparticles demonstrate broad tissue distribution and rapid clearance in vivoNanoparticles as protein and gene carriers to mucosal surfaces.Multifunctional Composite Microcapsules for Oral Delivery of Insulin.Challenges and advances in nanoparticle-based oral insulin delivery.Advances in oral macromolecular drug delivery.Current understanding of synergistic interplay of chitosan nanoparticles and anticancer drugs: merits and challenges.Peroral administration of 14C-poly(D,L-lactic acid) nanoparticles coated with human serum albumin or polyvinyl alcohol to guinea pigs.In vitro evaluation of nanoparticle formulations containing gangliosides.Hydrophobic ion pairing of an insulin-sodium deoxycholate complex for oral delivery of insulin.Nanoparticles and microparticles for drug and vaccine delivery.Oral protein drug delivery.Advances and opportunities in delivery of therapeutic proteins and peptides.Insulin-S.O (sodium oleate) complex-loaded PLGA nanoparticles: formulation, characterization and in vivo evaluation.Influence of polymers ratio on insulin-loaded nanoparticles based on poly-epsilon-caprolactone and Eudragit RS for oral administration.Enhancement of absorption of insulin-loaded polyisobutylcyanoacrylate nanospheres by sodium cholate after oral and subcutaneous administration in diabetic rats.In-vitro release and oral bioactivity of insulin in diabetic rats using nanocapsules dispersed in biocompatible microemulsion.Pluronic F127-based ocular delivery system containing biodegradable polyisobutylcyanoacrylate nanocapsules of pilocarpine.Methylprednisolone acetate-Eudragit® RS100 electrospuns: Preparation and physicochemical characterization.Formulation of insulin-loaded polymeric nanoparticles using response surface methodology.Bioadhesive properties of Gantrez nanoparticles.Alginate-containing systems for oral delivery of superoxide dismutase. Comparison of various configurations and their properties.Encapsulation of hydrophilic and lipophilic drugs in PLGA nanoparticles by the nanoprecipitation method.Developments in polymeric devices for oral insulin deliveryNovel alginate gel microspheres produced by impinging aerosols for oral delivery of proteinsBioadhesive properties of poly(anhydride) nanoparticles coated with different molecular weights chitosan
P2860
Q21198761-D391C22C-73A5-4D19-A328-A5AFFAC9997FQ24632900-09FC2E9B-49FA-4D0D-A0A5-4464DBDB2EC5Q26744008-C4B776DD-65BC-4011-94A3-589A37BF7B58Q26779447-E1C038FA-22D3-4EFD-AAA8-B2A025F53F5CQ26999867-BD55BC00-7256-41AA-B677-A632A926EE0BQ33882052-7A9AE024-013C-4762-8197-1041AD7D5333Q34532529-7BE85B4E-88E5-41AF-8075-D89114BB2C4EQ35248662-5F74DFEC-7AD7-4E87-B861-2B80A69D0A01Q35618421-B4D372C9-0121-4730-938F-9A55C34F9734Q35743320-669E21A4-748E-4BB6-87C0-DBED1AC911D9Q36232650-A956E2A0-75F5-4DCB-BC2A-542A05B150ADQ36527739-96FBD609-4E55-4688-8261-A935CB2A108EQ37002665-CD5814E8-88E6-45AE-813F-73F824377B28Q37015849-79EFF11F-687A-4DF8-90FF-983D63185876Q37039026-A9106F5A-8F87-4804-B039-EF83AF085CF5Q37178530-B67C81CA-D8F3-439A-A3AD-D0D2A7E819ECQ37331802-4BDE98DF-EA76-4AAA-86A5-CD15C47317AEQ37631458-9F5FBD12-B9D4-49B4-867C-01F2AB35D8CEQ37632407-14E49385-DE73-4BC6-BB7A-DE4F6FBFCEF7Q38235506-35B08DED-944D-403D-8C45-F746923203B2Q38362427-4676344A-AAAA-43E4-91F3-EA898DAD0DDAQ38547881-3AAB1799-0D83-486E-BBD2-978BC04B226FQ38569653-B63849D9-187C-4A26-A1EE-4DE9BFC5A720Q39599106-24D56EBE-6955-4D78-A084-A28A5E0B8F24Q41292073-1EEF59ED-7168-4A26-8EC2-FA310901C4DCQ41332213-3FB17D07-6771-4A91-8135-85E4D265EED5Q41493254-CACBE272-1E51-4B38-B998-84AEB230DC01Q43180563-5A51CAFB-D58E-4574-82B7-6BE9DD6B6093Q43259046-8BEE22F8-B4DD-4366-8FF7-6077FCA8CA29Q43837836-7CFE7CDD-1A81-482E-A871-356982C60582Q43985252-EE65CB35-35A9-4C37-99B6-526130EC89BCQ45386999-CD1C2812-3A83-406B-99CD-0359185971D3Q45754039-BDAA93A8-7BFF-4B20-9B0A-422DC317EF41Q46385824-F127B698-B58E-4969-B923-05A298260E9CQ46897266-3881723D-2FE1-4199-A14E-8A3BA636E3ECQ51279263-416F96CC-11CB-4DE4-9525-F7A172F957EAQ51466557-EAFCCAB2-DD52-4C4A-B9E2-2177E03FDCDCQ57349681-90CA294F-6DB1-40BF-9011-B2AC0F9DC7E6Q57382753-F6305132-67E6-4FE8-AD84-D093637230D4Q58152954-9DF78E21-EB45-49A4-80C5-90F529789E37
P2860
New approach for oral administration of insulin with polyalkylcyanoacrylate nanocapsules as drug carrier.
description
1988 nî lūn-bûn
@nan
1988年の論文
@ja
1988年学术文章
@wuu
1988年学术文章
@zh-cn
1988年学术文章
@zh-hans
1988年学术文章
@zh-my
1988年学术文章
@zh-sg
1988年學術文章
@yue
1988年學術文章
@zh
1988年學術文章
@zh-hant
name
New approach for oral administ ...... nanocapsules as drug carrier.
@ast
New approach for oral administ ...... nanocapsules as drug carrier.
@en
type
label
New approach for oral administ ...... nanocapsules as drug carrier.
@ast
New approach for oral administ ...... nanocapsules as drug carrier.
@en
prefLabel
New approach for oral administ ...... nanocapsules as drug carrier.
@ast
New approach for oral administ ...... nanocapsules as drug carrier.
@en
P2093
P356
P1433
P1476
New approach for oral administ ...... nanocapsules as drug carrier.
@en
P2093
P304
P356
10.2337/DIAB.37.2.246
P407
P577
1988-02-01T00:00:00Z